Polycysteus ovarium: een hormonaal en metabool syndroom
Rol van voedingsstoffen

Polycysteus-ovariumsyndroom (PCOS) is de meest voorkomende hormonale aandoening bij vrouwen en treft 3% tot 15% van alle vrouwen, afhankelijk van de diagnostische criteria. Kenmerken van het syndroom zijn te hoge niveaus van mannelijke hormonen (hyperandrogenisme), abnormale ovulatie en afwijkingen in de ovaria ('polycystes' en/of ovariumvolume van >10 ml).1 Het syndroom is sterk genetisch bepaald, maar staat tegelijkertijd onder invloed van omgevingsfactoren, in de eerste plaats factoren die ontstaan geven aan het metabool syndroom (metS). PCOS is de meest voorkomende oorzaak van onvruchtbaarheid.2 Dat brengt ons onmiddellijk bij een paradox: een veelvoorkomende en erg genetisch bepaalde eigenschap die de voorplanting belemmert.

Beste bezoeker, u heeft geen toegang.

Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.

U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!

Auteur

Joost Meeusen

Verschenen in

Referenties

  1. Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: What's new? Adv Clin Exp Med. 2017 Mar-Apr;26(2):359-367

  2. Corbett S, Morin-Papunen L. The Polycystic Ovary Syndrome and recent human evolution. Mol Cell Endocrinol. 2013 Jul 5;373(1-2):39-50

  3. Ünlütürk U, Sezgin E, Yildiz BO. Evolutionary determinants of polycystic ovary syndrome: part 1. Fertil Steril. 2016 Jul;106(1):33-41

  4. Fessler DMT, Natterson-Horowitz B, Azziz R. Evolutionary determinants of polycystic ovary syndrome: part 2. Fertil Steril. 2016 Jul;106(1):42-47

  5. Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012 Nov-Dec;18(6):618-37

  6. Hallajzadeh J, Khoramdad M, Karamzad N et al. Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis. J Cardiovasc Thorac Res. 2018;10(2):56-69

  7. Lim SS, Kakoly NS, Tan JWJ et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. 2018 Oct 19. doi: 10.1111/obr.12762

  8. Jiskoot G, Benneheij SH, Beerthuizen A et al. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial. Reprod Health. 2017 Mar 6;14(1):34

  9. Moran LJ, et al. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011;2:CD007506.

  10. Domecq JP, Prutsky G, Mullan RJ et al. Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. J Clin Endocrinol Metab. 2013 Dec;98(12):4655-63

  11. Brennan L, Teede H, Skouteris H et al. Lifestyle and behavioral management of polycystic ovary syndrome. J Womens Health (Larchmt). 2017 Aug;26(8):836-848

  12. Cooney LG, Milman LW, Hantsoo L et al. Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial. Fertil Steril. 2018 Jul 1;110(1):161-171.e1

  13. Moran LJ, Ko H, Misso M et al. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet. 2013 Apr;113(4):520-45

  14. Harrison CL, Lombard CB, Moran LJ, Teede HJ. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2011 Mar-Apr;17(2):171-83

  15. Orio F, Muscogiuri G, Giallauria F et al. Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial. Clin Endocrinol (Oxf). 2016 Nov;85(5):764-771

  16. Nybacka Å, Hellström PM, Hirschberg AL. Increased fibre and reduced trans fatty acid intake are primary predictors of metabolic improvement in overweight polycystic ovary syndrome-Substudy of randomized trial between diet, exercise and diet plus exercise for weight control. Clin Endocrinol (Oxf). 2017 Dec;87(6):680-688. doi: 10.1111/cen.13427

  17. Haqq L, McFarlane J, Dieberg G, Smart N. Effect of lifestyle intervention on the reproductive endocrine profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis. Endocr Connect. 2014 Feb 28;3(1):36-46

  18. Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016 Oct;37(5):467-520

  19. Luque-Ramírez M, Escobar-Morreale HF. Targets to treat androgen excess in polycystic ovary syndrome. Expert Opin Ther Targets. 2015;19(11):1545-60

  20. Yang K, Zeng L, Bao T, Ge J. Effectiveness of omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2018 Mar 27;16(1):27. doi: 10.1186/s12958-018-0346-x.

  21. Tang XL, Sun Z, Gong L. Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis. J Obstet Gynaecol Res. 2018 Jan;44(1):134-143

  22. Maleki V, Izadi A, Farsad-Naeimi A, Alizadeh M. Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review. Nutr Res. 2018 Aug;56:1-10. doi: 10.1016/j.nutres.2018.04.003

  23. Ashoush S, Abou-Gamrah A, Bayoumy H, Othman N. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial. J Obstet Gynaecol Res. 2016 Mar;42(3):279-85

  24. Wei W, Zhao H, Wang A et al. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol. 2012 Jan;166(1):99-105

  25. An Y, Sun Z, Zhang Y et al. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf). 2014 Mar;80(3):425-31

  26. Li L, Li C, Pan P et al. A single arm pilot study of effects of berberine on the menstrual pattern, ovulation rate, hormonal and metabolic profiles in anovulatory chinese women with polycystic ovary syndrome. PLoS One. 2015 Dec 8;10(12):e0144072

  27. Grant P. Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial. Phytother Res. 2010 Feb;24(2):186-8. doi: 10.1002/ptr.2900.

  28. Zare R, Nadjarzadeh A, Zarshenas MM et al. Efficacy of cinnamon in patients with type II diabetes mellitus: A randomized controlled clinical trial. Clin Nutr. 2018 Mar 11. pii: S0261-5614(18)30114-6

  29. Borzoei A, Rafraf M, Asghari-Jafarabadi M. Cinnamon improves metabolic factors without detectable effects on adiponectin in women with polycystic ovary syndrome. Asia Pac J Clin Nutr. 2018;27(3):556-563

  30. Kort DH, Lobo RA. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial. Am J Obstet Gynecol. 2014 Nov;211(5):487.e1-6

  31. Swaroop A, Jaipuriar AS, Gupta SK et al. Efficacy of a novel fenugreek seed extract (Trigonella foenum-graecum, Furocyst) in Polycystic ovary syndrome (PCOS). Int J Med Sci. 2015 Oct 3;12(10):825-31. doi: 10.7150/ijms.13024. eCollection 2015.

  32. Mansour A, Hosseini S, Larijani B et al. Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome. EXCLI J. 2016 Sep 5;15:551-564

  33. Karamali M, Eghbalpour S, Rajabi S et al. Effects of Probiotic Supplementation on Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Arch Iran Med. 2018 Jan 1;21(1):1-7

  34. Jamilian M, Mansury S, Bahmani F et al. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. J Ovarian Res. 2018 Sep 14;11(1):80

  35. Dastorani M, Aghadavod E, Mirhosseini N et al. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization. Reprod Biol Endocrinol. 2018 Oct 4;16(1):94

  36. Trummer C, Pilz S, Schwetz V et al. Vitamin D, PCOS and androgens in men: a systematic review. Endocr Connect. 2018 Mar;7(3):R95-R113

  37. Xue Y, Xu P, Xue K, Duan X, Cao J, Luan T, Li Q, Gu L. Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women: a meta-analysis. Archives of Gynecology and Obstetrics 2017. 295 487–496. (10.1007/s00404-016-4247-y)

  1. Łagowska K, Bajerska J, Jamka M. The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2018 Nov 2;10(11). pii: E1637

  2. Dastorani M, Aghadavod E, Mirhosseini N et al. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization. Reprod Biol Endocrinol. 2018 Oct 4;16(1):94

  3. Merhi Z. Crosstalk between advanced glycation end products and vitamin D: A compelling paradigm for the treatment of ovarian dysfunction in PCOS. Mol Cell Endocrinol. 2019 Jan 5;479:20-26

  4. Spinedi E, Cardinali DP. The Polycystic Ovary Syndrome and the metabolic syndrome: a possible chronobiotic-cytoprotective adjuvant therapy. Int J Endocrinol. 2018 Jul 25;2018:1349868

  5. Tagliaferri V, Romualdi D, Scarinci E et al. Melatonin treatment may be able to restore menstrual cyclicity in women with PCOS: A pilot study. Reprod Sci. 2018 Feb;25(2):269-275. doi: 10.1177/1933719117711262

  6. Pacchiarotti A, Carlomagno G, Antonini G, Pacchiarotti A. Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecol Endocrinol. 2016;32(1):69-73

  7. González F. Nutrient-induced inflammation in polycystic ovary syndrome: role in the development of metabolic aberration and ovarian dysfunction. Semin Reprod Med. 2015 Jul;33(4):276-86

  8. Barrea L, Marzullo P, Muscogiuri G et al. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome. Nutr Res Rev. 2018 Dec;31(2):291-301

  9. Salama AA, Amine EK, Salem HA, Abd El Fattah NK. Anti-Inflammatory Dietary Combo in Overweight and Obese Women with Polycystic Ovary Syndrome. N Am J Med Sci. 2015 Jul;7(7):310-6

  10. Asemi Z, Samimi M, Tabassi Z et al. Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial. Nutrition. 2014 Nov-Dec;30(11-12):1287-93

  11. Foroozanfard F, Rafiei H, Samimi M et al. The effects of dietary approaches to stop hypertension diet on weight loss, anti-Müllerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial. Clin Endocrinol (Oxf). 2017 Jul;87(1):51-58

  12. Azadi-Yazdi M, Karimi-Zarchi M, Salehi-Abargouei A et al. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial. J Hum Nutr Diet. 2017 Jun;30(3):275-283

  13. Asemi Z, Esmaillzadeh A. DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial. Horm Metab Res. 2015 Mar;47(3):232-8

  14. Izadi A, Ebrahimi S, Shirazi S et al. Hormonal and metabolic effects of coenzyme Q10 and/or vitamin E in patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2019 Feb 1;104(2):319-327

  15. Günalan E, Yaba A, Yılmaz B. The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: A critical review. J Turk Ger Gynecol Assoc. 2018 Nov 15;19(4):220-232

  16. Behrouzi Lak T, Hajshafiha M, Nanbakhsh F, Oshnouei S. N-acetyl cysteine in ovulation induction of PCOS women underwent intrauterine insemination: An RCT. Int J Reprod Biomed (Yazd). 2017 Apr;15(4):203-208

  17. Maged AM, Elsawah H, Abdelhafez A et al. The adjuvant effect of metformin and N-acetylcysteine to clomiphene citrate in induction of ovulation in patients with polycystic ovary syndrome. Gynecol Endocrinol. 2015;31(8):635-8

  18. Talari HR, Poladchang S, Hamidian Y et al. The effects of omega-3 and vitamin E co-supplementation on carotid intima-media thickness and inflammatory factors in patients with polycystic ovary syndrome. Oman Med J. 2018 Nov;33(6):473-479

  19. Rahmani E, Samimi M, Ebrahimi FA et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome. Mol Cell Endocrinol. 2017 Jan 5;439:247-255

  20. Akbari M, Ostadmohammadi V, Lankarani KB et al. The effects of vitamin D supplementation on biomarkers of inflammation and oxidative stress among women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Horm Metab Res. 2018 Apr;50(4):271-279

  21. Lindheim L, Bashir M, Münzker J et al. Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): A pilot study. PLoS One. 2017 Jan 3;12(1):e0168390

  22. Karamali M, Kashanian M, Alaeinasab S, Asemi Z. The effect of dietary soy intake on weight loss, glycaemic control, lipid profiles and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomised clinical trial. J Hum Nutr Diet. 2018 Feb 22. doi: 10.1111/jhn.12545

  23. Jamilian M, Asemi Z. The Effects of soy isoflavones on metabolic status of patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2016 Sep;101(9):3386-94. doi: 10.1210/jc.2016-1762. Epub 2016 Aug 4.

  24. Banaszewska B, Wrotyńska-Barczyńska J, Spaczynski RZ et al. Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2016 Nov;101(11):4322-4328

  25. Jamilian M, Sabzevar NK, Asemi Z. The effect of magnesium and vitamin E co-supplementation on glycemic control and markers of cardio-metabolic risk in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Horm Metab Res. 2018 Oct 4. doi: 10.1055/a-0749-6431

  26. Genazzani AD, Shefer K, Della Casa D et al. Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. J Endocrinol Invest. 2018 May;41(5):583-590

  27. De Cicco S, Immediata V, Romualdi D et al. Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action. Gynecol Endocrinol. 2017 Sep;33(9):698-701.

  28. Rago R, Marcucci I, Leto G et al. Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study. J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):913-23.

  29. Samimi M, Jamilian M, Ebrahimi FA et al. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf). 2016 Jun;84(6):851-7

  30. Jamilian H, Jamilian M, Samimi M et al. Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Gynecol Endocrinol. 2017 Jun;33(6):442-447

  31. Razavi M, Jamilian M, Kashan ZF et al. Selenium supplementation and the effects on reproductive outcomes, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome. Horm Metab Res. 2016 Mar;48(3):185-90

  32. Mohammad Hosseinzadeh F, Hosseinzadeh-Attar MJ, Yekaninejad MS, Rashidi B. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: A randomized, double blinded, placebo controlled clinical trial. J Trace Elem Med Biol. 2016 Mar;34:56-61. doi: 10.1016/j.jtemb.2016.01.002

  33. Meng Y, Chen X, Peng Z et al. Association between high serum homocysteine levels and biochemical characteristics in women with polycystic ovarian syndrome: A Systematic review and meta-analysis. PLoS One. 2016 Jun 9;11(6):e0157389

  34. Spritzer PM, Barone CR, Oliveira FB. Hirsutism in polycystic ovary syndrome: pathophysiology and management. Curr Pharm Des. 2016;22(36):5603-5613.

  35. Hassanzadeh Bashtian M, Emami SA, Mousavifar N et al. Evaluation of Fenugreek (Trigonella foenum-graceum L.), Effects Seeds Extract on Insulin Resistance in Women with Polycystic Ovarian Syndrome. Iran J Pharm Res. 2013 Spring;12(2):475-81.

  36. Jamilian M, Bahmani F, Siavashani MA et al. The Effects of chromium supplementation on endocrine profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res. 2016 Jul;172(1):72-8

  37. Maktabi M, Jamilian M, Asemi Z. Magnesium-zinc-calcium-vitamin D co-supplementation improves hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res. 2018 Mar;182(1):21-28.

  38. Jamilian M, Samimi M, Mirhosseini N et al. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome. J Affect Disord. 2018 Oct 1;238:32-38

  39. Nemati M, Nemati S, Taheri AM, Heidari B. Comparison of metformin and N-acetyl cysteine, as an adjuvant to clomiphene citrate, in clomiphene-resistant women with polycystic ovary syndrome. J Gynecol Obstet Hum Reprod. 2017 Sep;46(7):579-585

  40. Jamilian M, Foroozanfard F, Bahmani F et al. Effects of zinc supplementation on endocrine outcomes in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res. 2016 Apr;170(2):271-8

  41. Razavi M, Jamilian M, Kashan ZF et al. Selenium supplementation and the effects on reproductive outcomes, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome. Horm Metab Res. 2016 Mar;48(3):185-90

  42. Minozzi M, D'Andrea G, Unfer V. Treatment of hirsutism with myo-inositol: a prospective clinical study. Reprod Biomed Online. 2008 Oct;17(4):579-82

  43. Gateva A, Unfer V, Kamenov Z. The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. Gynecol Endocrinol. 2018 Jul;34(7):545-550

  44. Sortino MA, Salomone S, Carruba MO, Drago F. Polycystic ovary syndrome: insights into the therapeutic approach with inositols. Front Pharmacol. 2017 Jun 8;8:341